Imperial Oil (TSE: IMO) has recently received a number of price target changes and ratings updates:
- 10/15/2025 – Imperial Oil was downgraded by analysts at CIBC from a “neutral” rating to an “underperform” rating. They now have a C$110.00 price target on the stock, up previously from C$108.00.
- 10/7/2025 – Imperial Oil had its price target raised by analysts at Royal Bank Of Canada from C$115.00 to C$117.00. They now have a “sector perform” rating on the stock.
- 9/30/2025 – Imperial Oil was downgraded by analysts at TD Securities from a “hold” rating to a “sell” rating. They now have a C$104.00 price target on the stock, up previously from C$102.00.
- 9/25/2025 – Imperial Oil had its price target raised by analysts at Royal Bank Of Canada from C$108.00 to C$115.00. They now have a “sector perform” rating on the stock.
Imperial Oil Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, October 1st. Stockholders of record on Wednesday, October 1st were paid a dividend of $0.74 per share. This is a boost from Imperial Oil’s previous quarterly dividend of $0.72. The ex-dividend date was Thursday, September 4th. This represents a $2.96 annualized dividend and a dividend yield of 2.5%. Imperial Oil’s dividend payout ratio is currently 29.11%.
Imperial Oil is one of Canada’s largest integrated oil companies, focusing on upstream operations, petroleum refining operations, and the marketing of petroleum products. Production averaged 398 thousand barrels of oil equivalent per day in 2020. The company estimates that it holds 5.2 billion boe of proved and probable crude oil and natural gas reserves.
Featured Articles
- Five stocks we like better than Imperial Oil
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to Start Investing in Real Estate
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Imperial Oil Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperial Oil Limited and related companies with MarketBeat.com's FREE daily email newsletter.